Technical Analysis for ENSC - Ensysce Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.58 | 6.86% | 0.04 |
ENSC closed up 6.86 percent on Friday, April 26, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Doji - Bearish? | Reversal | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | 6.86% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 6.86% | |
| Outside Day | Range Expansion | 6.86% | |
| Wide Bands | Range Expansion | 6.86% | |
| Oversold Stochastic | Weakness | 6.86% | |
| NR7 | Range Contraction | 4.58% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 7 hours ago |
| Rose Above 10 DMA | about 7 hours ago |
| Up 10% | about 7 hours ago |
| Up 1 ATR | about 7 hours ago |
| 10 DMA Resistance | about 9 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Ensysce Biosciences, San Diego, CA is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin Activated Abuse Protection (TAAP™) and Multi-Pill Abuse Resistance (MPAR™) platforms, the Company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce’s products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing the human and economic cost. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.
Sector: Industrials
Industry: Conglomerates
Keywords: Health Sciences Pain Pharmacy Psychoactive Drugs Opioids Heroin Morphine Drug Culture Opioid Use Disorder
Classification
Sector: Industrials
Industry: Conglomerates
Keywords: Health Sciences Pain Pharmacy Psychoactive Drugs Opioids Heroin Morphine Drug Culture Opioid Use Disorder
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.2 |
| 52 Week Low | 0.53 |
| Average Volume | 173,333 |
| 200-Day Moving Average | 1.25 |
| 50-Day Moving Average | 0.77 |
| 20-Day Moving Average | 0.69 |
| 10-Day Moving Average | 0.59 |
| Average True Range | 0.06 |
| RSI (14) | 32.89 |
| ADX | 33.54 |
| +DI | 13.85 |
| -DI | 25.48 |
| Chandelier Exit (Long, 3 ATRs) | 0.70 |
| Chandelier Exit (Short, 3 ATRs) | 0.70 |
| Upper Bollinger Bands | 0.90 |
| Lower Bollinger Band | 0.48 |
| Percent B (%b) | 0.25 |
| BandWidth | 61.47 |
| MACD Line | -0.08 |
| MACD Signal Line | -0.07 |
| MACD Histogram | -0.0083 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.70 | ||||
| Resistance 3 (R3) | 0.70 | 0.66 | 0.68 | ||
| Resistance 2 (R2) | 0.66 | 0.63 | 0.66 | 0.67 | |
| Resistance 1 (R1) | 0.62 | 0.62 | 0.60 | 0.62 | 0.67 |
| Pivot Point | 0.59 | 0.59 | 0.58 | 0.59 | 0.59 |
| Support 1 (S1) | 0.55 | 0.56 | 0.53 | 0.55 | 0.50 |
| Support 2 (S2) | 0.51 | 0.54 | 0.51 | 0.50 | |
| Support 3 (S3) | 0.47 | 0.51 | 0.49 | ||
| Support 4 (S4) | 0.47 |
